Preliminary comparison of neuropsychological performance in patients with non-small-cell lung cancer treated with chemotherapy or targeted therapy

par Kang HL, Chen VCH, Hung WL, Hsiao HP, Wang WH
Publié 2019

Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report

par Albina S. Zhabina, Fedor V. Moiseenko, Nikita M. Volkov, Nuriniso Kh. Abduloeva, Vladimir M. Moiseenko
Publié 2021

Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation

par Tian Tian, Min Yu, Juan Li, Maoqiong Jiang, Daiyuan Ma, Shubin Tang, Zhiyu Lin, Lin Chen, Youling Gong, Jiang Zhu, Qiang Zhou, Meijuan Huang, You Lu
Publié 2021

Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues

par Teresa WM Fan, Richard M Higashi, Huan Song, Saeed Daneshmandi, Angela L Mahan, Matthew S Purdom, Therese J Bocklage, Thomas A Pittman, Daheng He, Chi Wang, Andrew N Lane
Publié 2021

ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors

par Elena Corral de la Fuente, Amparo Benito Berlinches, Ana Gomez Rueda, María Eugenia Olmedo García, Yolanda Lage Alfranca, Margaret Lario, Almudena Santón Roldán, Pilar Garrido
Publié 2021

Oligoprogression in Non-Small Cell Lung Cancer

par Daijiro Harada, Nagio Takigawa
Publié 2021

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study

par Khan M, Zhao Z, Li X, Liao G
Publié 2021

Circular RNA SMARCA5 Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer by miR-19b-3p/HOXA9 Axis [Retraction]

par Wang Y, Li H, Lu H, Qin Y
Publié 2021

Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer

par Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Publié 2016

Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

par Somasundaram A, Burns TF
Publié 2017

Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma

par Svetlana V. Odintsova, Mariia A. Sviridenko, Antonina O. Cheremnykh, Elena A. Filippova, Magaripa A. Urtenova, Sergei V. Orlov
Publié 2020

Construction of circRNA-miRNA-mRNA network and identification of novel potential biomarkers for non-small cell lung cancer

par Jia Yang, Ran Hao, Yunlong Zhang, Haibin Deng, Wenjing Teng, Zhongqi Wang
Publié 2021

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer

par Brazel D, Nagasaka M
Publié 2021

A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer

par Jianyuan Zhou, Sijuan Zou, Dong Kuang, Jianhua Yan, Jun Zhao, Jun Zhao, Xiaohua Zhu
Publié 2021

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

par Jie Qian, Weimin Wang, Weimin Wang, Lin Wang, Jun Lu, Lele Zhang, Bo Zhang, Shuyuan Wang, Wei Nie, Yanwei Zhang, Yuqing Lou, Baohui Han
Publié 2021

Short 2-[18F]Fluoro-2-Deoxy-D-Glucose PET Dynamic Acquisition Protocol to Evaluate the Influx Rate Constant by Regional Patlak Graphical Analysis in Patients With Non-Small-Cell Lu...

par Luca Indovina, Valentina Scolozzi, Amedeo Capotosti, Stelvio Sestini, Silvia Taralli, Davide Cusumano, Romina Grazia Giancipoli, Gabriele Ciasca, Gabriele Ciasca, Giuseppe Cardillo, Maria Lucia Calcagni, Maria Lucia Calcagni
Publié 2021

Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib

par Mengqiu Tang, Chao Song, Yaowen Zhang, Xiaoyu Xu, Chen Wang, Zhanchun Zhang, Tian Chen
Publié 2021

Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients

par Yahua Wu, Haishan Wu, Mingqiang Lin, Tianxiu Liu, Jiancheng Li
Publié 2022

LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway

par Yaomei He, Xiulin Jiang, Lincan Duan, Qiuxia Xiong, Yixiao Yuan, Peishen Liu, Liping Jiang, Qiushuo Shen, Song Zhao, Cuiping Yang, Yongbin Chen
Publié 2021

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer

par Nathaniel Wiest, Umair Majeed, Karan Seegobin, Yujie Zhao, Yanyan Lou, Rami Manochakian
Publié 2021